HELP US FIND OUT MORE ABOUT ENDOMETRIOSIS
Give back by helping us fund endometriosis research today!
2023 Grant Recipients
Uterine NK cell dysfunction in endometriosis pathobiology
- Dorien Feyaerts, PhD
- Brice Gaudilliere, MD, PhD
- Linda Giudice, MD, PhD
- Marina Sirota, PhD
- Stanford University School of Medicine, CA, USA
Assessment of Reproductive Health Improvement in Endometriosis by novel STING inhibitors (ARIES)
- Luis Villacorta, PhD, FAHA
- Indrajit Chowdhuri, PhD
- Winston E. Thompson, PhD
- Morehouse School of Medicine, Atlanta, GA
Uterine adenomyosis: elucidating the etiopathogenesis and proposing new diagnostic biomarkers
- Prof. Marie-Madeleine Dolmans, MD, PhD
- Prof. Jacques Donnez, MD, PhD
- Christina Anna Stratopoulou, MSc
- Margherita Zipponi, MSc
- Chloé Beaussart, MD, PhD
- Olivier Van Kerk
- Dolores Gonzalez
- GYNE research laboratory, IREC, Université Catholique de Louvain
Modeling Endometriosis: Uncovering the Role of Dendritic Cells in Perpetuating Disease.
- Elise Courtois, PhD
- Nelio Oliveira, PhD
- Joshua Lee, MD/PhD candidate
- The Jackson Laboratory Foundation, Farmington, CT USA 06032
Define the Role of Humoral Immunity in the Pathophysiology of Endometriosis
- Diane F. Jelinek, Ph.D.
- Dr. Khash Khazaie, Ph.D.
- Joseph Grande, M.D., Ph.D.
- Karen Anderson M.D., Ph.D.
- Zaraq Khan, M.B.B.S., M.S.
- Johnny Yi, M.D.
- Megan Wasson, M.D.
- Mayo Clinic Arizona
Disclaimer:
Endofound is a charitable entity and is not committed to matching the indirect cost rates of the U.S. government or other entities. We believe our policy to allow no more than 10% of any Endofound research grant funding to go towards indirect costs is consistent with that of many private foundations and certain government entities that have a flat rate that caps the amount an applicant institution can charge. Endofound's policy helps ensure furtherance of our charitable purpose.
